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D 4.15 Vascular Registry Data
"It is the responsibility of every surgeon...to monitor his experience with care. Only those sur-
geons with acceptable results are ultimately qualified."! Although this quotation comes from an
editorial regarding carotid surgery, it is undoubtedly true for all kinds of vascular and endovas-
cular procedures. Carefully performed single-center audits are obviously of value, but larger reg-
istries enabling comparisons between centers, between treatments, and the study of time trends
have an even higher impact and should be even more reliable. (See also Recommendation 77, p
SI75).
Besides specific registries, such as the Vietnam Vascular Registry,2 a very early experience came
from the Cleveland Vascular Society, reporting a large-scale computerized registration.f More
recent registries have been reported from the Society for Clinical Vascular Surgerys and the
Upstate New York Vascular Societyf More recent experiences come from Scandinavia with the
Swedish Vascular Registry (SWEDVASC) starting in 1987, followed by the FINN-VASC, the
Danish KARBASE, and the Norwegian NORKAR.
An important difference between the Scandinavian and North American registries reported
above is that the former are intended to cover entire countries. Regarding SWEDVASC, this
was accomplished from early 1994 after a successive increase of the number of hospitals from its
initiation in 1987.6 Recently, experiences have been presented from a New Zealand vascular
registry, from Northern Ireland and from The Netherlands (personal communication).
D 4.15.1 Problems With Vascular Registry Data
Limitations may be that long-term results are not easily obtained. Both FINNVASC and the
Danish registry have found data after 30 days difficult to retrieve. 7,8,9,10 The Swedish Vascular
Registry has a I-year follow-up rate after surgery for chronic limb ischemia of92%, whereas
endovascular procedures are less frequently reported. There is an apparent risk that patients not
followed-up are worse than those who are followed-up. In a study of femoral distal bypass pro-
cedures, 12% were lost to follow-up. Compared with followed-up patients, those lost to follow-
up had mortality rates of 29% versus 19% and patency rates of 43% versus 68%.11 Also, a Danish
follow-up has convincingly shown that patients lost to follow-up had a significantly increased
rate of graft thrombosis, limb amputation, and death.l- On average the I-year follow-up rate in
SWEDVASC now exceeds 90%. Longer-term follow-up would be beneficial but is not realistic.
Conversely, in countries in which it is possible to connect a national registry to a population
registry, long-term mortality rates would at least be achievable. This has been used in studies
based on outcome in the SWEDVASC registry.l"
One problem is that epidemiology data are not easily retrieved, because nonintervention cases
and amputations are not recorded in current registries. Another drawback is that if all operative
details are considered important, a registry protocol has to be extensive, and this can be cum-
bersome. Compromise, therefore, has to be the solution, which means that uniformity, for
instance using Reporting Standards, has not yet been possible.14,15,16
D 4.15.2 Advantages of Vascular Registries
Advantages of vascular registries include that surgeons frequently receive feedback, initiate pro-
fessional debate, improve self-assessment, and develop better decision making. One example is
the accumulation of data from treatment of ALI, which has expedited a change from hazardous
thrombectomies to more reasonable thrombolysis.s A registry may be a good guide to identify
accumulation of "sentinel events" that need further investigation; for example, although there is
a risk of myocardial infarction after surgery for intermittent claudication, the risk of this or
amputation is higher after other kinds of vascular surgery. A vascular registry may allow devia-
tions from standards to be detected more quickly, and quality improvement measures then may
be initiated.
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Important questions have been raised concerning the validity and reliability aspects of a registry.
This has been discussed after the l O-year experiences of the SWEDVASC.6 The concern is pri-
marilywhether all procedures have been included in the registry, whether all patients are fol-
lowed-up, and whether the data included are correct and complete. As described, unfavorable
results are reported less frequently than favorable results, which is a drawback. For example,
patency rates of 70% to 90% have been reported for femoral distal bypass after 1 year. In a
recent, fully audited study of more than 500 patients, the true patency rate was less than 60%.17
A reasonable explanation may be that single centers may have different case mixes or that
patients are lost to follow-up.
Whether all data need to be included is a matter of debate. One of the difficult issues is to have
risk factors reported. It was recently shown that smoking increased the risk for both reoperation
in ALI and elective aortic aneurysm surgery. Hypertension had the same effect in emergency
aortic aneurysm surgeryl ''. It is therefore assumed that risk factors are of great importance in a
full audit.
Registries are of value to study time trends and differences between geographical areas. From
the SwedishVascular Registry, it is evident that as much as 49% of all procedures are performed
for CLI, but a larger proportion than expected is performed for IC. The quotient IC/CLI
varies between health care regions from 0.62 to 1.23. From 11.7 to 37.0 procedures per
100,000 inhabitants are performed annually for CLI and reported to SWEDVASC-a figure
lower than expected given that the proportion of new CLI patients ranges from 500 to 1,000
per 100,000 population annually.
Endovascular procedures are used increasingly. On average, 47% of interventional procedures
registered in the SWEDVASC between 1987 and 1996 were performed using endovascular
techniques. In the proximal (aortoiliofemoral) region, endovascular procedures now constitute
73% of cases, compared with 30% in 1987. For the distal (femoropopliteal) above-knee region,
corresponding increases are from 25% to 50%. For CLI, infrainguinal procedures constitute 88%
of all procedures. The 30-day amputation and mortality rates range between 7% and 11% with-
out significant differences between the various locations of lesions for surgical procedures. In a
follow-up of almost 5,000 surgical and endovascular procedures below the groin for CLI, the
late survival rate was calculated. The 6-year cumulative survival rate was significantly higher for
patients with a patent reconstruction after 1 year and also for those who did not have amputa-
tions, despite an occluded reconstruction, compared with those who underwent an amputation.
This was particularly true after surgery, whereas after PTA only a patent segment indicated a
better cumulative survival rate.l 3
National vascular registries have a great impact on the attitude of vascular surgeons, provided
that they are involved in the process. Discussions and debates regarding the outcome of the
registry variables might help to understand drawbacks of treatments or variations in outcomes.
At the very least, it is helpful to find out whether treatments are of value for a particular patient
category, for instance, whether a distal bypass procedure is of any lasting benefit for the patient
or whether severe complications to carotid surgery might reduce the value of carotid
endarterectomy.
Critical Issue 43: Influence of vascular registries on patient management
There is a need to establish how vascular registries benefit the management of patients
with peripheral arterial disease on a population basis.
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D 4.16 Other Treatment Modalities
The treatment modalities considered here are not necessarilyconfined to eLI patients but are
sometimes also used in claudicants.
D 4.16.1 Transfusion of Ultraviolet Irradiated Autologous Blood
This technique is widely used in patients with PAD in all stages, mostly in eastern countries of
Europe and Russia. Photohemotherapy consists of ultraviolet radiation of autologous blood.
Although a few uncontrolled studies showed an improvement of rheological properties of the
blood, there is no controlled prospective study in patients with IC or CLI showing a clear clini-
cal benefit for the treated patients'!
D 4.16.2 Hyperbaric Oxygen
The initial reports on the use of hyperbaric oxygen in patients with early gangrene of the legs
were encouraging, because relief of pain was obtained and amputations could be postponed,
even for several years.2,a In an uncontrolled study, 18% of diabetic patients with ulcers refractory
to conventional treatment had complete healing, but all made at least a fair response. Seventy-
five percent of atherosclerotic ulcers in nondiabetic patients improved sufficiently to allow
patients to return home and resume daily activities.s The longest and largest experience was
reported by Predenuccif who collected data on more than 2,000 patients treated in over
70,000 sessions between 1966 and 1983. Relief ofrest pain and healing of limiting ulcers was
observed in one third of patients after 4 to 6 weeks of treatment. The therapy is cumbersome,
and it is also unclear to what extent the clinical results can be attributed to concomitant therapy,
